BioAge Labs Inc.
USD24.68
-0.27 (-1.08%)
CEO
Kristen Fortney
IPO Date
2024-09-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$24.77
Prev. Close
$24.95
Day Low
$24.31
Day High
$24.83
52W Low
$4.07
52W High
$25.80
Market Cap
$0.93B
Volume
0.02M
| 22,000 |
| $15.48 |
| 12 Jun 2026 | HEALY JAMES | director | A-Award | Acquired | 22,000 | $15.48 |
| 12 Jun 2026 | ENRIGHT PATRICK G | director | A-Award | Acquired | 22,000 | $15.48 |
| 12 Jun 2026 | Davidson Michael H. | director | A-Award | Acquired | 22,000 | $15.48 |
| 12 Jun 2026 | GARNIER JEAN PIERRE | director | A-Award | Acquired | 22,000 | $15.48 |
| 24 Apr 2026 | GOLDSTEIN DOV A MD | Chief Financial Officer | M-Exempt | Acquired | 3,542 | $4.38 |
| 24 Apr 2026 | GOLDSTEIN DOV A MD | Chief Financial Officer | M-Exempt | Disposed | 3,542 | $4.38 |
| 3 Apr 2026 | RUBIN PAUL D | Chief Medical Officer | M-Exempt | Acquired | 5,437 | $4.11 |
| 3 Apr 2026 | RUBIN PAUL D | Chief Medical Officer | M-Exempt | Acquired | 3,383 | $6.57 |